Activation of I2-imidazoline receptors enhances supraspinal morphine analgesia in mice: A model to detect agonist and antagonist activities at these receptors

British Journal of Pharmacology

Volumn 130, Issue 1, 2000, Pages 146-152

  Sánchez Blázquez, Pilar ^a,b   Assumpcio Boronat M ^c   Olmos, Gabriel ^c   García Sevilla, Jesús A ^c   Garzón, Javier ^a  

^a CSIC   (Spain)

^b INSTITUTO CAJAL   (Spain)

^c NONE

Author keywords

GTP binding proteins; Imidazoline receptors; Potentiation of morphine effects; Supraspinal antinociception

Indexed keywords

2 (2 BENZOFURANYL)IMIDAZOLE; 2 (2 IMIDAZOLIN 2 YL)QUINOLINE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 BFI; AGANODINE; AGMATINE; AGN 192403; ANALGESIC AGENT; CLORGYLINE; DELEQUAMINE; IDAZOXAN; IMIDAZOLINE I2 RECEPTOR; LAZABEMIDE; LIGAND; LSL 61103; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; MORPHINE; MOXONIDINE; N (2 AMINOETHYL) 4 CHLOROBENZAMIDE; PERTUSSIS TOXIN; RILMENIDINE; SELEGILINE; TRACIZOLINE; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0034100844     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703294     Document Type: Article

References (43)

1. 2 receptors, on glial fibrillary acidic protein concentration. Eur. J. Pharmacol., 280, 205-210.
2. 3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 39-47.
3. 2-imidazoline ligands. Br. J. Pharmacol., 125, 175-185.
4. 2-imidazoline binding sites in rat and rabbit tissues. Naunyn-Schmiedeberg's Arch. Pharmacol., 357, 351-355.
5. BOUSQUET, P., FF.LMAN, J. & SCHWARTZ, J. (1984). Central cardiovascular effects of alpha-adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther., 230, 232-236.
6. 2-adrenoceptor or μ opioid receptor mechanisms. Eur. J. Pharmacol., 331, 133-138.
7. 2-adrenoceptor antagonist. Br. J. Pharmacol., 108, 516-525.
8. 2 sites. J. Pharmacol. Exp. Ther., 272, 681-688.
9. 2 receptors. Eur. J. Pharmacol., 333, 9-15.
10. 2 subtypes. Fumdam. Clin. Pharmacol., 6, P18.
11. 2-imidazoline sites. J. Pharmacol. Exp. Ther., 264, 172-182.
12. FUENTES, J.A., GARZÓN, J. & DELRIO, J. (1977). Potentiation of morphine analgesia in mice after inhibition of brain type B monoamine oxidase. Neuropharmacology, 16, 857-862.
13. 3H]-RX821002, a 2-methoxy derivative of idazoxan. Br. J. Pharmacol., 100, 862-866.
14. GARZÓN, J., CASTRO, M. & SÁNCHEZ-BLÁZQUEZ, P. (1998). Influence of Gz and Gi2 transducer proteins in the activity of opioid agonists to μ receptors. Eur. J. Neurosci., 10, 2557-2564.
15. GARZÓN, J., GARCÍA-ESPAÑA, A. & SÁNCHEZ-BLAZQUEZ, P. (1997). Opioids binding mu and delta receptors exhibit diverse efficacy in the activation of Gi2 and Gx z transducer proteins in mouse periaqueductal gray matter. J. Pharmacol. Exp. Ther., 281, 549-557.
16. 2 imidazoline ligand, RS45041, potentiates hyperalgesia in acute arthritis. Neuroreport, 7, 1497-1501.
17. 2-sites). Br. J. Pharmacol., 112, 320.
18. KOLESNIKOV, Y., JAIN, S. & PASTERNAK, G.W. (1996). Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol., 296, 17-22.
19. 2-site ligand 2-2 Benzofuranyl-2imidazohne on in vivo noradrenaline release in rat brain. Br. J. Pharmacol., 114, 413P.
20. 2-adrenergic binding sites. Mol. Pharmacol., 37, 876-885.
21. LI, G., REGUHATHAN, S., BARROW, C.J., ESHRAGHI, J., COOPER, R. & REIS, D.J. (1994). Agmatine an endogenous clonidine-displacing substance in the brain. Science, 263, 966-969.
22. 2-adrenoceptors in the human heart: discrimination by clonidine and moxonidine. Naunyn Schmiedeberg's Arch. Pharmacol., 354, 689-692.
23. 2 receptors. Eur. J. Pharmacol., 304, 221-229.
24. MICHEL, M.C. & INSEL, P.A. (1989). Are there multiple imidazoline binding sites? Trends Pharmacol. Sci., 10, 342-344.
25. 3H]-RX821002 (2-methoxy idazoxan) in the human and rat brains. J. Pharmacol. Exp. Ther., 264, 1187-1197.
26. 1-imidazoline sites in bovine adrenal medulla membranes. Naunyn Schmiedeberg's Arch. Pharmacol., 348, 70-76.
27. OCAÑA, M., DEL POZO, E., BARRIOS, M., ROBLES, L.I. & BAEYENS, J.M. (1990). An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur. J. Pharmacol., 186, 377-380.
28. 3H]-idazoxan binding sites in the rat brain. Br. J. Pharmacol., 108, 597-603.
29. 2-imidazoline receptors in rat liver. Br. J. Pharmacol., 121, 901-912.
30. 2 adrenergic receptors. J. Pharmacol. Exp. Ther., 272, 581-587.
31. RADDATZ, R., PARINI, A. & LANIER, S.M. (1995). Imidazoline-guanidium binding domains on monoamine oxidases. J. Biol. Chem., 270, 27961-27968.
32. REGUHATHAN, S., EVINGER, M.J., MEELEY, M.P. & REIS, D.J. (1991). Effects of clonidine and other imidazoline-receptor binding agents on second messenger systems and calcium influx in bovine adrenal medulla chromafin cells. Biochem. Pharmacol., 42, 2011-2018.
33. REGUHATHAN, S., FEINSTEIN, D.L. & REIS, D.J. (1993). Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes. J. Neurosci. Res., 34, 681-688.
34. REGUNATHAN, S. & REIS, D.J. (1996). Imidazoline receptors and their endogenous ligands. Annu. Rev. Pharmacol. Toxicol., 36, 511-544.
35. RUGGIERO, D.A., REGUHATHAN, S., WANG, H., MILNER, T.A. & REIS, D.J. (1998). Immunocytochemical localization of an imidazoline receptor protein in the central nervous system. Brain Res., 780, 270-293.
36. + currents in Xenopus oocytes. Eur. J. Pharmacol., 259, 223-231.
37. SÁNCHEZ-BLÁZQUEZ, P., GARCÍA-ESPAÑA, A. & GARZÓN, J. (1995). In vivo injection of oligodeoxynucleotides to Gα subunits and supraspinal analgesia evoked by mu and delta opioid agonists. J. Pharmacol. Exp. Ther., 275, 1590-1596.
38. SÁNCHEZ-BLÁZQUEZ, P. &GARZÓN, J. (1988). Pertussis toxin differentially reduces the efficacy of opioids to produce supraspinal analgesia in the mouse. Eur. J. Pharmacol., 152, 357-361.
39. SÁNCHEZ-BLÁZQUEZ, P., RODRIGUEZ-DIAZ, M., DE ANTONIO, I. & GARZÓN, J. (1999). Endomorphin-1 and -2 show differences in their activation of mu opioid receptor-regulated G proteins in supraspinal antinociception in mice. J. Pharmacol. Exp. Ther., 291, 12-18.
40. 2 with monoamine oxidase B sites. J. Neurochem., 61, 881-889.
41. 2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem., 270, 9856-9861.
42. TESSON, F. & PARINI, A. (1991). Identification of an imidazoline-guanidium receptive site in mitochondria from rabbit cerebral cortex. Eur. J. Pharmacol., 208, 81-83.
43. 2-adrenoeeptors? Eur. J. Pharmacol., 190, 203-215.